Prof Bernd Rosenkranz has a medical degree from the University of Düsseldorf and is board certified Pharmacologist and Clinical Pharmacologist in Germany and Fellow of the Faculty of Pharmaceutical Medicine (FFPM).
He has spent 23 years in industry, as Director of Clinical Pharmacology at Hoechst/Hoechst Marion Roussel in Germany, France and USA, Chief Medical Officer at the 3ClinicalResearch in Germany, and Vice President Clinical Development at the German biotech company, Jerini. Since 2008, he is Professor and Head of the Division of Clinical Pharmacology, Stellenbosch University (South Africa), where he is chair of the postgraduate programme in Pharmaceutical Medicine / Medicines Development (PharmaTrain Centre of Excellence).
Bernd Rosenkranz is President of Fundisa African Academy of Medicines Development, board member of the South African Society for Basic and Clinical Pharmacology (SASBCP), and secretary of the College of Clinical Pharmacologists (CMSA), He is member of the International Committee of the UK Faculty of Pharmaceutical Medicine, of the Membership Committee of the International Union of Basic and Clinical Pharmacology (IUPHAR), of the European PharmaTrain Federation, and of the PharmaTrain Certification Board. He is co-chair of the IFAPP-PharmaTrain “Medicines Development and Regulation: Working Group on Education in Low and Middle Income Countries”.
His work has been presented in 95 original publications, 17 book chapters, 59 invited lectures/chairmanships, and 116 conference presentations. He is Associate Editor of Frontiers in Pharmaceutical Medicine and Outcomes Research and Journal of Medicines Development Sciences.
Bernd Rosenkranz is board member of the Manenberg Aftercare Centre in Cape Town.